|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
RIVAROXABAN(O)
Test CodeRIVAROXABAN(O)
CPT Codes
92981
Preferred Specimen
1 mL plasma collected in a 3.2% sodium citrate (light blue-top) tube
Patient Preparation
Collect samples 2-4 hours post dose (peak)
Minimum Volume
0.5 mL
Transport Temperature
Frozen
Specimen Stability
Room temperature: Unacceptable
Refrigerated: Unacceptable
Frozen: 28 days
Refrigerated: Unacceptable
Frozen: 28 days
Methodology
Chromogenic
Setup Schedule
Mon, Wed, Fri
Report Available
1-4 days
Reference Range
Dosage | Peak mcg/L(at steady state) | Trough* mcg/L |
20 mg qD | 182-408 | 3-153 |
15 mg qD | 180-408 | 2-161 |
10 mg qD | 91-196 | 1-38 |
*The lower limit of detection for this assay is 30 mcg/L. The ranges are based on literature references (see FAQs). Click more information (below).
Clinical Significance
​Rivaroxaban - Rivaroxaban is an oral factor Xa inhibitor that is indicated to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. It is also indicated for the treatment, prophylaxis, or the reduction in the risk of reoccurrence of deep vein thrombosis (DVT) or pulmonary embolism (PE). Rivaroxaban does not need to be monitored routinely, however, exceptions may include determination of failure of therapy vs. poor compliance, or potential dose adjustment required for renal or hepatic dysfunction.
Performing Laboratory
Quest Diagnostics Nichols Institute
Additional Information
More information
Last Updated: May 22, 2025